3 results
Primary objectives of the study are to assess whether the administration of p53-SLP together with the local administration of IFNα is safe and able to induce a strong (directly ex-vivo detectable) p53-specific CD4+ T-cell response. Secondary…
Main objective: To evaluate the efficacy of BIIB122 225 mg compared with placebo.Secondary objective: To evaluate the efficacy, safety and tolerability of BIIB122 225 mg compared with placebo in participants with early-stage PDObjective optional (…
Our study uses a two-step approach. In the first step (study part 1), we will assess the feasibility of the ADJUST-AFO to measure the optimization parameter, walking energy cost, while changing the stiffness during 20 minutes walking in healthy…